Scaling up the Manufacturing Process of Adoptive T Cell Immunotherapy

Adoptive T cell immunotherapy, involving the reprogramming of immune cells to target specific cancer or virus‐infected cells, has been recognized as a promising novel approach for the treatment of complex diseases. The impressive global momentum of this therapeutic approach has highlighted the urgen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biotechnology journal 2019-04, Vol.14 (4), p.e1800239-n/a
Hauptverfasser:	Dai, Xiaofeng, Mei, Yi, Nie, Jianqi, Bai, Zhonghu
Format:	Artikel
Sprache:	eng
Schlagworte:	adoptive T cell immunotherapy automation Bioreactors Cell- and Tissue-Based Therapy - trends closed system Humans Immunotherapy, Adoptive - trends manufacturing model Neoplasms - immunology Neoplasms - therapy quality‐by‐design T-Lymphocytes - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!